Pulmonary Vascular Disease Center

Pulmonary Hypertension

Expert diagnosis and advanced treatment for pulmonary arterial hypertension (PAH) and all forms of PH.

Pulmonary hypertension diagnosis and treatment

Understanding Pulmonary Hypertension

Pulmonary Hypertension (PH) is a rare, progressive disorder characterized by high blood pressure in the arteries of the lungs, making the right side of the heart work harder to pump blood.

PH affects approximately 1% of the global population. Over time, increased pressure can weaken the right ventricle, leading to heart failure.

Critical: PH is often misdiagnosed as asthma or COPD. Early diagnosis by a specialist is crucial.

Types of PH (WHO Groups)

Group 1: Pulmonary Arterial Hypertension

Idiopathic, heritable, or associated with connective tissue disease, HIV, congenital heart disease.

Group 2: PH due to Left Heart Disease

Caused by left ventricular dysfunction or valvular disease.

Group 3: PH due to Lung Disease

Associated with COPD, interstitial lung disease, sleep apnea.

Group 4: Chronic Thromboembolic PH

Caused by blood clots that don't dissolve.

Common Symptoms

Symptoms often develop gradually and may be mistaken for other conditions.

😮‍💨

Shortness of Breath

Initially with exertion

😴

Fatigue

Overwhelming tiredness

🫀

Chest Pain

Angina-like pain

🦶

Swelling (Edema)

Ankles, legs, abdomen

😵

Dizziness/Fainting

During physical activity

🔵

Cyanosis

Bluish lips or skin

WHO Functional Classification

Class I

No limitation of physical activity. No dyspnea with exertion.

Class II

Slight limitation. Comfortable at rest, ordinary activity causes dyspnea.

Class III

Marked limitation. Less than ordinary activity causes symptoms.

Class IV

Unable to perform physical activity. Symptoms at rest.

Risk Factors & Causes

Medical Conditions

  • Connective tissue diseases
  • Congenital heart disease
  • Liver disease (portal hypertension)
  • HIV infection
  • Chronic lung disease

Other Risk Factors

  • Family history/genetic mutations
  • Female gender (2-4x more common)
  • High altitude living
  • Certain drugs/toxins

Diagnostic Approach

  • Echocardiogram: First-line test to estimate pulmonary artery pressure
  • Right Heart Catheterization: Gold standard for diagnosis
  • Pulmonary Function Tests: To rule out lung disease
  • V/Q Scan: To detect CTEPH
  • 6-Minute Walk Test: Assesses functional capacity

When to Seek Urgent Care

🚨 Seek immediate consultation if you have:

  • Worsening shortness of breath limiting daily activities
  • Chest pain that doesn't resolve with rest
  • Fainting episodes (syncope)
  • Rapidly increasing swelling in legs or abdomen

Advanced Treatment Options

💊 Targeted PAH Therapies

Prostacyclin Pathway Agents

Epoprostenol, Treprostinil, Selexipag

Endothelin Receptor Antagonists

Bosentan, Ambrisentan, Macitentan

PDE-5 Inhibitors

Sildenafil, Tadalafil

🫀 Supportive Therapies

  • Oxygen therapy
  • Diuretics for fluid retention
  • Anticoagulation (for CTEPH)

⚙️ Interventional/Surgical

  • Pulmonary Thromboendarterectomy
  • Atrial Septostomy
  • Lung or Heart-Lung Transplantation

Lifestyle Management

  • Low-sodium diet
  • Supervised exercise/rehabilitation
  • Avoid pregnancy (high risk)
  • Stay up-to-date with vaccinations

Prognosis & Outcomes

85-90%

1-year survival

70-75%

3-year survival

50-60%

5-year survival

Improving Outlook: With early diagnosis and modern therapy, survival rates have dramatically improved.

Why Choose Our PH Center?

Specialized care for pulmonary vascular disease

Multidisciplinary Team

Cardiology, Pulmonology, Rheumatology

Advanced Diagnostics

Right heart cath, V/Q scans, MRI

Access to Novel Therapies

Clinical trials & combination regimens

Lifelong Follow-up

Comprehensive disease management

Request a Consultation

Expert PH evaluation within 48 hours

Related Care

Explore associated treatments

PH Specialist Hotline

+91 813-044-8904

Available for urgent consultations

Mon-Sat: 10:00 AM - 7:00 PM